Stocks and Investing Stocks and Investing
Tue, July 20, 2021

Geoffrey Porges Downgraded (VRTX) to Sell and Decreased Target to $170 on, Jul 20th, 2021


Published on 2024-10-27 17:15:05 - WOPRAI, Geoffrey Porges
  Print publication without navigation


Geoffrey Porges of SVB Leerink, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Sell and Decreased Target from $200 to $170 on, Jul 20th, 2021.

Geoffrey has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 2 agree with Geoffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Danielle Brill of "Raymond James" Initiated at Hold on, Thursday, July 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $205 on, Friday, June 11th, 2021


These are the ratings of the 11 analyists that currently disagree with Geoffrey


  • Brian Abrahams of "RBC Capital" Maintained at Buy and Held Target at $246 on, Saturday, July 10th, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $261 on, Monday, June 14th, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $240 on, Friday, June 11th, 2021
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $244 on, Friday, June 11th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021
Contributing Sources